Clinical trial

Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response

NCT04150341

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-11-06

PhasePHASE2

Study timeline

Study start (actual)2019-11-06Date precision: day

Registry last updated2022-03-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

TD-8236DRUG

PlaceboDRUG

Sponsors & collaborators

Theravance Biopharmalead sponsor

Mapped research locations

LondonUnited Kingdom1 ManchesterUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04150341 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.